Audentes Therapeutics, Inc. - Insider Trading & Ownership

Entity
Company
Location
600 California St., 17 Th Floor, San Francisco, CA
Summary
The estimated value of insider holdings of Audentes Therapeutics, Inc. is at least $11.8M dollars as of October 31, 2022. Audentes Therapeutics, Inc. is the 10%+ Owner of Taysha Gene Therapies, Inc. and owns shares of Taysha Gene Therapies, Inc. (TSHA) stock worth about $11.8M.
All Insider Reports
All Insider Reports

Ownership of Audentes Therapeutics, Inc.

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
TSHA Taysha Gene Therapies, Inc. 10%+ Owner $11.8M Oct 21, 2022

There are no insider transactions reported by Audentes Therapeutics, Inc.